Fundz

Terremoto Biosciences Appoints James Christensen, Ph.D., as President and Head of Research & Development

PRIVATEJan 10, 2025

Position

Head of Research

Company

Terremoto Biosciences

James Christensen
jchristensen@terremotobio.com
San FranciscoInformation TechnologyBiotechnologyScience And Engineering

Description

Terremoto Biosciences announced the appointment of James Christensen, Ph.D., as President and Head of Research & Development. His extensive experience in precision oncology drug development and proven track record align perfectly with the company’s goal to discover and develop novel therapies for patients in need.

Other recent leadership changes in Science And Engineering and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Terremoto Biosciences, and when

A new leader at Terremoto Biosciences brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Terremoto Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Terremoto Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Terremoto Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Terremoto Biosciences

Location

San Francisco, California, United States

About

Terremoto Biosciences is a covalent drug discovery and development engine creating highly targeted, small molecule medicines with unmatched selectivity, potency and efficacy. The company leverages the power of lysine-based covalency across the disease spectrum to develop both best-in-class therapies against known drug targets and first-in-class medicines against the previously undruggable. Many of Terremoto’s founders helped establish this emergent area of science, with the intent to broaden the number of tractable targets and deliver medicines with superior therapeutic benefit. Terremoto is supported by leading investors OrbiMed and Third Rock Ventures.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Terremoto Biosciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

James
Likely contact at this company
••••••••@••••••••

See James's verified email →

James
Senior decision-maker at this company
••••••••@••••••••

See James's verified email →

Ronald
Senior decision-maker at this company
••••••••@••••••••

See Ronald's verified email →

Paul
Senior decision-maker at this company
••••••••@••••••••

See Paul's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Terremoto Biosciences's next move

Learn about Strategic plan

Terremoto Biosciences changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.